Managing the symptom burden associated with maintenance dialysis : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Copyright © 2023 Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. All rights reserved..
Individuals with kidney failure undergoing maintenance dialysis frequently report a high symptom burden that can interfere with functioning and diminish life satisfaction. Until recently, the focus of nephrology care for dialysis patients has been related primarily to numerical targets for laboratory measures, and outcomes such as cardiovascular disease and mortality. Routine symptom assessment is not universal or standardized in dialysis care. Even when symptoms are identified, treatment options are limited and are initiated infrequently, in part because of a paucity of evidence in the dialysis population and the complexities of medication interactions in kidney failure. In May of 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference-Symptom-Based Complications in Dialysis-to identify the optimal means for diagnosing and managing symptom-based complications in patients undergoing maintenance dialysis. Participants included patients, physicians, behavioral therapists, nurses, pharmacists, and clinical researchers. They outlined foundational principles and consensus points related to identifying and addressing symptoms experienced by patients undergoing dialysis and described gaps in the knowledge base and priorities for research. Healthcare delivery and education systems have a responsibility to provide individualized symptom assessment and management. Nephrology teams should take the lead in symptom management, although this does not necessarily mean taking ownership of all aspects of care. Even when options for clinical response are limited, clinicians should focus on acknowledging, prioritizing, and managing symptoms that are most important to individual patients. A recognized factor in the initiation and implementation of improvements in symptom assessment and management is that they will be based on locally existing needs and resources.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:104 |
|---|---|
| Enthalten in: |
Kidney international - 104(2023), 3 vom: 20. Sept., Seite 441-454 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mehrotra, Rajnish [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Health-related quality of life |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 29.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.kint.2023.05.019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357924037 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357924037 | ||
| 003 | DE-627 | ||
| 005 | 20231226073639.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.kint.2023.05.019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1193.xml |
| 035 | |a (DE-627)NLM357924037 | ||
| 035 | |a (NLM)37290600 | ||
| 035 | |a (PII)S0085-2538(23)00399-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mehrotra, Rajnish |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Managing the symptom burden associated with maintenance dialysis |b conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 29.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Individuals with kidney failure undergoing maintenance dialysis frequently report a high symptom burden that can interfere with functioning and diminish life satisfaction. Until recently, the focus of nephrology care for dialysis patients has been related primarily to numerical targets for laboratory measures, and outcomes such as cardiovascular disease and mortality. Routine symptom assessment is not universal or standardized in dialysis care. Even when symptoms are identified, treatment options are limited and are initiated infrequently, in part because of a paucity of evidence in the dialysis population and the complexities of medication interactions in kidney failure. In May of 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a Controversies Conference-Symptom-Based Complications in Dialysis-to identify the optimal means for diagnosing and managing symptom-based complications in patients undergoing maintenance dialysis. Participants included patients, physicians, behavioral therapists, nurses, pharmacists, and clinical researchers. They outlined foundational principles and consensus points related to identifying and addressing symptoms experienced by patients undergoing dialysis and described gaps in the knowledge base and priorities for research. Healthcare delivery and education systems have a responsibility to provide individualized symptom assessment and management. Nephrology teams should take the lead in symptom management, although this does not necessarily mean taking ownership of all aspects of care. Even when options for clinical response are limited, clinicians should focus on acknowledging, prioritizing, and managing symptoms that are most important to individual patients. A recognized factor in the initiation and implementation of improvements in symptom assessment and management is that they will be based on locally existing needs and resources | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a health-related quality of life | |
| 650 | 4 | |a hemodialysis | |
| 650 | 4 | |a kidney failure | |
| 650 | 4 | |a patient-reported outcome measures | |
| 650 | 4 | |a peritoneal dialysis | |
| 650 | 4 | |a symptoms | |
| 700 | 1 | |a Davison, Sara N |e verfasserin |4 aut | |
| 700 | 1 | |a Farrington, Ken |e verfasserin |4 aut | |
| 700 | 1 | |a Flythe, Jennifer E |e verfasserin |4 aut | |
| 700 | 1 | |a Foo, Marjorie |e verfasserin |4 aut | |
| 700 | 1 | |a Madero, Magdalena |e verfasserin |4 aut | |
| 700 | 1 | |a Morton, Rachael L |e verfasserin |4 aut | |
| 700 | 1 | |a Tsukamoto, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Unruh, Mark L |e verfasserin |4 aut | |
| 700 | 1 | |a Cheung, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Jadoul, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Winkelmayer, Wolfgang C |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Edwina A |e verfasserin |4 aut | |
| 700 | 0 | |a Conference Participants |e verfasserin |4 aut | |
| 700 | 1 | |a Bagasha, Peace |e investigator |4 oth | |
| 700 | 1 | |a Bargman, Joanne M |e investigator |4 oth | |
| 700 | 1 | |a Bavanandan, Sunita |e investigator |4 oth | |
| 700 | 1 | |a Beckwith, Hannah |e investigator |4 oth | |
| 700 | 1 | |a Bennett, Paul N |e investigator |4 oth | |
| 700 | 1 | |a Bohm, Clara |e investigator |4 oth | |
| 700 | 1 | |a Brennan, Frank |e investigator |4 oth | |
| 700 | 1 | |a Burton, James O |e investigator |4 oth | |
| 700 | 1 | |a Cavanaugh, Kerri L |e investigator |4 oth | |
| 700 | 1 | |a Chilcot, Joseph |e investigator |4 oth | |
| 700 | 1 | |a Choi, Peter |e investigator |4 oth | |
| 700 | 1 | |a Cukor, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Dember, Laura M |e investigator |4 oth | |
| 700 | 1 | |a Dong, Jie |e investigator |4 oth | |
| 700 | 1 | |a Edwards, Dawn |e investigator |4 oth | |
| 700 | 1 | |a Erickson, Kevin F |e investigator |4 oth | |
| 700 | 1 | |a Figueiredo, Ana |e investigator |4 oth | |
| 700 | 1 | |a Finkelstein, Fredric O |e investigator |4 oth | |
| 700 | 1 | |a Fukagawa, Masafumi |e investigator |4 oth | |
| 700 | 1 | |a Germain, Michael |e investigator |4 oth | |
| 700 | 1 | |a Guillano, Franklin B |e investigator |4 oth | |
| 700 | 1 | |a Hurst, Helen |e investigator |4 oth | |
| 700 | 1 | |a Iseki, Kunitoshi |e investigator |4 oth | |
| 700 | 1 | |a Jardine, Meg J |e investigator |4 oth | |
| 700 | 1 | |a Jauré, Allison |e investigator |4 oth | |
| 700 | 1 | |a Jha, Vivekanand |e investigator |4 oth | |
| 700 | 1 | |a Jhamb, Manisha |e investigator |4 oth | |
| 700 | 1 | |a Kanjanabuch, Talerngsak |e investigator |4 oth | |
| 700 | 1 | |a Lerma, Edgar |e investigator |4 oth | |
| 700 | 1 | |a Kam-Tao Li, Philip |e investigator |4 oth | |
| 700 | 1 | |a Liew, Adrian |e investigator |4 oth | |
| 700 | 1 | |a Małyszko, Jolanta |e investigator |4 oth | |
| 700 | 1 | |a Proenca de Moraes, Thyago |e investigator |4 oth | |
| 700 | 1 | |a Moranne, Olivier |e investigator |4 oth | |
| 700 | 1 | |a Nam Ng, Marques Shek |e investigator |4 oth | |
| 700 | 1 | |a Ostermann, Marlies |e investigator |4 oth | |
| 700 | 1 | |a Perl, Jeffrey |e investigator |4 oth | |
| 700 | 1 | |a Pigford, Jayne |e investigator |4 oth | |
| 700 | 1 | |a Pommer, Wolfgang |e investigator |4 oth | |
| 700 | 1 | |a Richardson, Michelle M |e investigator |4 oth | |
| 700 | 1 | |a Rivara, Matthew B |e investigator |4 oth | |
| 700 | 1 | |a Roberts, Glenda V |e investigator |4 oth | |
| 700 | 1 | |a Sarafidis, Pantelis |e investigator |4 oth | |
| 700 | 1 | |a Shroff, Rukshana |e investigator |4 oth | |
| 700 | 1 | |a Slon Roblero, Maria Fernanda |e investigator |4 oth | |
| 700 | 1 | |a Smyth, Brendan |e investigator |4 oth | |
| 700 | 1 | |a Søndergaard, Henning |e investigator |4 oth | |
| 700 | 1 | |a Van Der Veer, Sabine N |e investigator |4 oth | |
| 700 | 1 | |a Vassalotti, Joseph A |e investigator |4 oth | |
| 700 | 1 | |a Vervloet, Marc |e investigator |4 oth | |
| 700 | 1 | |a Vincent, Lloyd |e investigator |4 oth | |
| 700 | 1 | |a Walker, Rachael |e investigator |4 oth | |
| 700 | 1 | |a Warren, Madeleine |e investigator |4 oth | |
| 700 | 1 | |a Wasylynuk, Betty Ann |e investigator |4 oth | |
| 700 | 1 | |a West, Melissa |e investigator |4 oth | |
| 700 | 1 | |a Wilkie, Caroline |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international |d 1972 |g 104(2023), 3 vom: 20. Sept., Seite 441-454 |w (DE-627)NLM000007188 |x 1523-1755 |7 nnns |
| 773 | 1 | 8 | |g volume:104 |g year:2023 |g number:3 |g day:20 |g month:09 |g pages:441-454 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.kint.2023.05.019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 104 |j 2023 |e 3 |b 20 |c 09 |h 441-454 | ||